Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
Nick Jonas was diagnosed with Type 1 diabetes when he was 13 years old. Since then, the pop star and actor has become a very public face for those managing the chronic health condition. In 2021, he starred in a Super Bowl campaign for a diabetes monitoring device by Dexcom and this year, after the brand sat out the 2022 game, Jonas is back to promote the new version of Dexcom’s continuous glucose monitoring system (CGM), the G7.
The new ad, which will air during the second quarter of the game, is meant to raise awareness of CGMs and help people control their health without the inconvenience and pain associated with finger sticks.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in